INTERFERON-FREE TREATMENT WITH A COMBINATION OF MERICITABINE AND DANOPREVIR/R WITH OR WITHOUT RIBAVIRIN IN TREATMENT-NAIVE HCV GENOTYPE 1-INFECTED PATIENTS

被引：40

作者：

Gane, E. J. ^{[1
]}

Pockros, P. ^{[2
,3
]}

Zeuzem, S. ^{[4
]}

Marcellin, P. ^{[5
]}

Shikhman, A. ^{[6
]}

Bernaards, C. ^{[7
]}

Yetzer, E. S. ^{[7
]}

Shulman, N. ^{[7
]}

Tong, X. ^{[6
]}

Najera, I. ^{[6
]}

Bertasso, A. ^{[6
]}

Hammond, J. ^{[6
]}

Stancic, S. ^{[6
]}

机构：

[1] Auckland Clin Studies, Auckland, New Zealand

[2] Scripps Clin, La Jolla, CA USA

[3] Scripps Translat Sci Inst, La Jolla, CA USA

[4] JW Goethe Univ Hosp, Frankfurt, Germany

[5] Hop Beaujon, Clichy, France

[6] Roche, Nutley, NJ USA

[7] Genentech Inc, San Francisco, CA 94080 USA

来源：

关键词：

D O I：

10.1016/S0168-8278(12)61423-8

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

1412

引用

页码：S555 / S556

页数：2